1. Takaishi M, Sano S：Transdifferentiation of melanoma cells by the reprogramming factors attenuates malignant nature in vitro and in vivo．
J Invest Dermatol, 139(1):254-257, 2019
2. Yamamoto T, Ohtsuki M, Sano S, Morita A, Igarashi A, Okuyama R, Kawada A：Switching biologics in the treatment of psoriatic arthritis in Japan．
J Dermatol, 46(3):e113-e114, 2019
3. Hashida Y, Higuchi T, Tanaka M, Shibata Y, Nakajima K, Sano S, Daibata M：Prevalence and Viral Loads of Cutaneous Human Polyomaviruses in the Skin of Patients with Chronic Inflammatory Skin Diseases．
J Infect Dis, 219(10):1564-1573, 2019
4. Nakajima K, Kataoka S, Sato K, Takaishi M, Yamamoto M, Nakajima H, Sano S：Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production．
J Dermatol Sci, 93(2):82-91, 2019
5. Ohko K,Nakajima K,Kataoka S,Takaishi M,Sano S：IL-36 signaling is essential for psoriatic inflammation through the augmentation of innate immune responses.
J Invest Dermatol, 139(6):1400-1404, 2019
6. Yamamoto T, Ohtsuki M, Sano S, Morita A, Igarashi A, Okuyama R, Kawada A: Late-onset psoriatic arthritis in Japanese patients．J Dermatol．
J Dermatol, 46(2):169-170, 2019
7. Nakagawa H, Tanaka Y, Sano S, Kameda H,Taniguchi A, Kashiwagi T, Kawaberi T, Kimura J, Morita A：Real-World Postmarketing Studyof the Impact of Adalimumab Treatment on Work Productivity and ActivityImpairment in Patients with Psoriatic Arthritis.
Adv Ther, 36(3):691-707, 2019
8. Okazaki S, Osawa R, Nakajima H, Nakajima K, Sano S：Favorable response to apremilastin a patient with refractory psoriasis verrucosa.
J Dermatol, 46(6):544-547, 2019
9. Okamura K, Hayashi M, Abe Y, Kono M, Nakajima K, Aoyama Y, Nishigori C, Ishimoto H, Ishimatsu Y, Nakajima M,Hozumi Y, Suzuki T：NGS-based targeted resequencingidentified rare subtypes of albinism: Providing accurate molecular diagnosisfor Japanese patients with albinism.
Pigment Cell Melanoma Res,32(6):848-853, 2019
10. Shibata Y, Serada S, Fujimoto M, Oishi T,Ohko K, Fujieda M, Naka T, Sano S：Myosin heavy chain, a novelallergen for fish allergy in patients with atopic dermatitis.
Br J Dermatol, 181(6):1322-1324, 2019
11. Morisaka H, Morisaka H, Yoshimi K, Okuzaki Y, Gee P, Kunihiro Y, Sonpho E, Xu H, Sasakawa N, Naito Y, Nakada S, Yamamoto T, Sano S, Hotta A, Takeda J, Mashimo T：CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.
